Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer

G Viglietto, ML Motti, P Bruni, RM Melillo, A D'alessio… - Nature medicine, 2002 - nature.com
G Viglietto, ML Motti, P Bruni, RM Melillo, A D'alessio, D Califano, F Vinci, G Chiappetta
Nature medicine, 2002nature.com
The cyclin-dependent kinase inhibitor p27kip1 is a putative tumor suppressor for human
cancer. The mechanism underlying p27kip1 deregulation in human cancer is, however,
poorly understood. We demonstrate that the serine/threonine kinase Akt regulates cell
proliferation in breast cancer cells by preventing p27kip1-mediated growth arrest. Threonine
157 (T157), which maps within the nuclear localization signal of p27kip1, is a predicted Akt-
phosphorylation site. Akt-induced T157 phosphorylation causes retention of p27kip1 in the …
Abstract
The cyclin-dependent kinase inhibitor p27kip1 is a putative tumor suppressor for human cancer. The mechanism underlying p27kip1 deregulation in human cancer is, however, poorly understood. We demonstrate that the serine/threonine kinase Akt regulates cell proliferation in breast cancer cells by preventing p27kip1-mediated growth arrest. Threonine 157 (T157), which maps within the nuclear localization signal of p27kip1, is a predicted Akt-phosphorylation site. Akt-induced T157 phosphorylation causes retention of p27kip1 in the cytoplasm, precluding p27kip1-induced G1 arrest. Conversely, the p27kip1-T157A mutant accumulates in cell nuclei and Akt does not affect p27kip1–T157A-mediated cell cycle arrest. Lastly, T157-phosphorylated p27kip1 accumulates in the cytoplasm of primary human breast cancer cells coincident with Akt activation. Thus, cytoplasmic relocalization of p27kip1, secondary to Akt-mediated phosphorylation, is a novel mechanism whereby the growth inhibitory properties of p27kip1 are functionally inactivated and the proliferation of breast cancer cells is sustained.
nature.com